Custom Search
Monday, October 22, 2007
Salary levels for Post-Doctoral fellows in research institutes
How much a biology postdoc can earn nowadays? The answer is "depends". The salary levels vary across the country, most times depending who you are working for. However, in the top research institutes, there are guidelines in terms of compensation levels for postdocs and graduate students.
The table above is the brief surveys of postdoc salary levels in prestigious research institutes. The average is based on the data collected in 2006.
The table above is the brief surveys of postdoc salary levels in prestigious research institutes. The average is based on the data collected in 2006.
Sources: US Department of Labor
Tuesday, October 16, 2007
Biopharmaceuticals: Approval Trends in 2006
Note: click on the table for better view.
The year 2006 witnessed the approval of 13 biopharmaceuticals in the United States or European Union (Table 1) including four hormones, three antibody-based products, three therapeutic enzymes, one recombinant vaccine, an anticlotting agent, and a nucleic acid–based product. Major target indications included hereditary genetic conditions (four products), growth deficiency (two products), and neovascular macular degeneration (two products).
Only 10 of the 13 products were genuinely new to the market. Naglazyme, Tysabri, and Macugen, although approved in one region last year, had gained approval before 2006 in some other world region.
In terms of expression systems used, five of the approved biopharmaceuticals are produced in mammalian cell lines, four in Escherichia coli, and two in Saccharomyces cerevisiae, again confirming the prominence of these three expression systems in the biopharmaceutical sector. One product (Macugen) is produced by solid-phase organic synthesis. Another (Atryn) is particularly noteworthy because it is the first biopharmaceutical produced in a transgenic animal to gain regulatory approval.
For full text of this article, please click here.
Written by
Source: BioPharminternational.com
The year 2006 witnessed the approval of 13 biopharmaceuticals in the United States or European Union (Table 1) including four hormones, three antibody-based products, three therapeutic enzymes, one recombinant vaccine, an anticlotting agent, and a nucleic acid–based product. Major target indications included hereditary genetic conditions (four products), growth deficiency (two products), and neovascular macular degeneration (two products).
Only 10 of the 13 products were genuinely new to the market. Naglazyme, Tysabri, and Macugen, although approved in one region last year, had gained approval before 2006 in some other world region.
In terms of expression systems used, five of the approved biopharmaceuticals are produced in mammalian cell lines, four in Escherichia coli, and two in Saccharomyces cerevisiae, again confirming the prominence of these three expression systems in the biopharmaceutical sector. One product (Macugen) is produced by solid-phase organic synthesis. Another (Atryn) is particularly noteworthy because it is the first biopharmaceutical produced in a transgenic animal to gain regulatory approval.
For full text of this article, please click here.
Written by
Source: BioPharminternational.com
Monday, October 15, 2007
CNN - 071012 - Al Gore Wins Nobel Peace Prize - Announcement
Al Gore Nobel Peace Prize Press Conference
Sunday, October 14, 2007
The Nobel Peace Prize 2007
The Nobel Peace Prize goes to the Intergovernmental Panel on Climate Change (IPCC) and Albert Arnold (Al) Gore Jr. "for their efforts to build up and disseminate greater knowledge about man-made climate change, and to lay the foundations for the measures that are needed to counteract such change"
Check the official website for details!
Check the official website for details!
Wednesday, October 10, 2007
Journal Impact Factors for 2005: top 200!
Journal Title | Impact Factor |
CA-CANCER J CLIN | 49.794 |
ANNU REV IMMUNOL | 47.4 |
NEW ENGL J MED | 44.016 |
ANNU REV BIOCHEM | 33.456 |
NAT REV CANCER | 31.694 |
SCIENCE | 30.927 |
NAT REV IMMUNOL | 30.458 |
REV MOD PHYS | 30.254 |
NAT REV MOL CELL BIO | 29.852 |
CELL | 29.431 |
NATURE | 29.273 |
NAT MED | 28.878 |
PHYSIOL REV | 28.721 |
NAT IMMUNOL | 27.011 |
NAT GENET | 25.797 |
ANNU REV NEUROSCI | 24.184 |
ANNU REV CELL DEV BI | 23.69 |
LANCET | 23.407 |
JAMA-J AM MED ASSOC | 23.332 |
NAT BIOTECHNOL | 22.738 |
ENDOCR REV | 22.538 |
NAT REV NEUROSCI | 20.951 |
CHEM REV | 20.869 |
ANNU REV PHARMACOL | 19.833 |
NAT CELL BIOL | 19.717 |
NAT REV GENET | 19.211 |
NAT REV DRUG DISCOV | 18.775 |
CANCER CELL | 18.725 |
ANNU REV ASTRON ASTR | 18.567 |
SURF SCI REP | 17.857 |
ANNU REV PLANT BIOL | 17.78 |
REV PHYSIOL BIOCH P | 17.053 |
ANNU REV BIOPH BIOM | 16.175 |
PROG POLYM SCI | 16.045 |
NAT MATER | 15.941 |
PHARMACOL REV | 15.689 |
GENE DEV | 15.61 |
MICROBIOL MOL BIOL R | 15.5 |
NAT NEUROSCI | 15.456 |
CURR OPIN CELL BIOL | 15.246 |
J NATL CANCER I | 15.171 |
PROG SOLID STATE CH | 15.167 |
IMMUNITY | 15.156 |
J CLIN INVEST | 15.053 |
MOL CELL | 14.971 |
TRENDS ECOL EVOL | 14.864 |
PLOS BIOL | 14.672 |
DEV CELL | 14.609 |
ASTROPHYS J SUPPL S | 14.428 |
TRENDS NEUROSCI | 14.325 |
NEURON | 14.304 |
NAT REV MICROBIOL | 13.989 |
J EXP MED | 13.965 |
ANNU REV GENET | 13.959 |
CHEM SOC REV | 13.747 |
ANNU REV MICROBIOL | 13.412 |
ANNU REV PHYS CHEM | 13.405 |
ANNU REV PHYSIOL | 13.359 |
TRENDS BIOCHEM SCI | 13.343 |
MASS SPECTROM REV | 13.273 |
ANN INTERN MED | 13.254 |
ACCOUNTS CHEM RES | 13.141 |
AM J HUM GENET | 12.649 |
ARCH GEN PSYCHIAT | 12.642 |
GASTROENTEROLOGY | 12.386 |
NAT STRUCT MOL BIOL | 12.19 |
LANCET NEUROL | 12.167 |
BBA-REV CANCER | 12.143 |
TRENDS GENET | 12.047 |
J CLIN ONCOL | 11.81 |
TRENDS CELL BIOL | 11.791 |
PROG NEUROBIOL | 11.789 |
CURR BIOL | 11.732 |
CIRCULATION | 11.632 |
PROG LIPID RES | 11.372 |
ANNU REV MATER RES | 11.219 |
PLANT CELL | 11.088 |
J CELL BIOL | 10.951 |
CURR OPIN PLANT BIOL | 10.807 |
LANCET INFECT DIS | 10.521 |
MAT SCI ENG R | 10.517 |
PHYS REP | 10.458 |
CLIN MICROBIOL REV | 10.443 |
ADV PHYS | 10.421 |
FRONT NEUROENDOCRIN | 10.409 |
ANNU REV MED | 10.383 |
TRENDS PHARMACOL SCI | 10.372 |
SYST BIOL | 10.327 |
P NATL ACAD SCI USA | 10.231 |
TRENDS IMMUNOL | 10.174 |
GENOME RES | 10.139 |
BLOOD | 10.131 |
ANNU REV ECOL EVOL S | 10.104 |
ANNU REV GENOM HUM G | 10.094 |
EMBO J | 10.053 |
FEMS MICROBIOL REV | 10 |
ALDRICHIM ACTA | 9.917 |
BEHAV BRAIN SCI | 9.885 |
MOL CELL PROTEOMICS | 9.876 |
NANO LETT | 9.847 |
HEPATOLOGY | 9.792 |
ANNU REV PSYCHOL | 9.784 |
COORDIN CHEM REV | 9.779 |
Q REV BIOPHYS | 9.765 |
PSYCHOL BULL | 9.746 |
GENOME BIOL | 9.712 |
TRENDS PLANT SCI | 9.701 |
ANGEW CHEM INT EDIT | 9.596 |
CURR OPIN STRUC BIOL | 9.559 |
ASTRON ASTROPHYS REV | 9.5 |
CIRC RES | 9.408 |
CURR OPIN GENET DEV | 9.361 |
MOL PSYCHIATR | 9.335 |
ANNU REV ENTOMOL | 9.326 |
ADV MICROB PHYSIOL | 9.3 |
OCEANOGR MAR BIOL | 9.25 |
J AM COLL CARDIOL | 9.2 |
TRENDS COGN SCI | 9.155 |
ADV MATER | 9.107 |
CURR OPIN IMMUNOL | 9.103 |
CYTOKINE GROWTH F R | 9.075 |
BRIT MED J | 9.052 |
ATHEROSCLEROSIS SUPP | 8.963 |
SEMIN IMMUNOL | 8.922 |
REP PROG PHYS | 8.893 |
AM J RESP CRIT CARE | 8.689 |
ANNU REV NUTR | 8.605 |
REJUV RES | 8.571 |
CURR OPIN NEUROBIOL | 8.527 |
ANNU REV FLUID MECH | 8.471 |
CURR OPIN CHEM BIOL | 8.451 |
IMMUNOL REV | 8.42 |
PLOS MED | 8.389 |
PHARMACOL THERAPEUT | 8.357 |
AM J PSYCHIAT | 8.286 |
J PHOTOCH PHOTOBIO C | 8.167 |
DIABETES | 8.028 |
CANCER METAST REV | 8.017 |
ARCH INTERN MED | 8.016 |
CURR OPIN MICROBIOL | 8.005 |
SEMIN CANCER BIOL | 7.99 |
PSYCHOL REV | 7.986 |
MED RES REV | 7.964 |
TRENDS BIOTECHNOL | 7.955 |
HUM MUTAT | 7.923 |
ADV CANCER RES | 7.909 |
LANCET ONCOL | 7.855 |
DIABETES CARE | 7.844 |
CELL DEATH DIFFER | 7.785 |
HUM MOL GENET | 7.764 |
DRUG DISCOV TODAY | 7.755 |
REV GEOPHYS | 7.742 |
CLIN CHEM | 7.717 |
GUT | 7.692 |
J ALLERGY CLIN IMMUN | 7.667 |
EMBO REP | 7.663 |
CANCER RES | 7.616 |
ANNU REV PHYTOPATHOL | 7.605 |
DEVELOPMENT | 7.603 |
PROG RETIN EYE RES | 7.577 |
ANN NEUROL | 7.571 |
NUCLEIC ACIDS RES | 7.552 |
BRAIN | 7.535 |
CLIN PHARMACOL THER | 7.526 |
J NEUROSCI | 7.506 |
PHYS REV LETT | 7.489 |
NEUROSCI BIOBEHAV R | 7.443 |
CRIT REV BIOCHEM MOL | 7.423 |
ARTH RHEUM/AR C RES | 7.421 |
J AM CHEM SOC | 7.419 |
CAN MED ASSOC J | 7.402 |
ACM COMPUT SURV | 7.4 |
EUR HEART J | 7.341 |
Q REV BIOL | 7.333 |
NAT PROD REP | 7.325 |
J AM SOC NEPHROL | 7.24 |
TRENDS ENDOCRIN MET | 7.22 |
SIAM REV | 7.213 |
ADV DRUG DELIVER REV | 7.189 |
MOL CELL BIOL | 7.093 |
FASEB J | 7.064 |
ARTERIOSCL THROM VAS | 7.053 |
PLANT J | 6.969 |
ANN RHEUM DIS | 6.956 |
J PROTEOME RES | 6.901 |
CURR OPIN BIOTECH | 6.898 |
ONCOGENE | 6.872 |
BIOESSAYS | 6.787 |
BIOL PSYCHIAT | 6.779 |
ADV FUNCT MATER | 6.77 |
NAT METHODS | 6.741 |
J COSMOL ASTROPART P | 6.739 |
TRENDS MICROBIOL | 6.648 |
LEUKEMIA | 6.612 |
RECENT PROG HORM RES | 6.571 |
J CELL SCI | 6.543 |
J BONE MINER RES | 6.527 |
MOL BIOL CELL | 6.52 |
CLIN INFECT DIS | 6.51 |
SEMIN CELL DEV BIOL | 6.491 |
Monday, October 8, 2007
Three winners of the Nobel Prize in Physiology or Medicine 2007
The $1.54 million prize was awarded Monday to Mario R. Capecchi, 70, of the University of Utah in Salt Lake City; Oliver Smithies, 82, a native of Britain now at University of North Carolina in Chapel Hill, and Sir Martin J. Evans, 66, of Cardiff University in Wales.
This year's Nobel Laureates have made a series of ground-breaking discoveries concerning embryonic stem cells and DNA recombination in mammals. Their discoveries led to the creation of an immensely powerful technology referred to as gene targeting in mice. It is now being applied to virtually all areas of biomedicine – from basic research to the development of new therapies.
Mario R. Capecchi Lab Webpage !
Oliver Smithies Lab Webpage !
Sir Martin J. Evans Lab Webpage !
Want to see more celebration photos, click here.
Sources: Nobel Foundation, Associated Press.
Wednesday, October 3, 2007
Predicts the Nobel Prizes in 2007
The announcement of the Nobel Prize in Physiology or Medicine is scheduled on next Monday, October 8, 2007.
Guess who will be the biggest winner in biomedical sciences this year?
Mainly based on the citations and impacts of the publications, Thomson Scientific has 6 nominees this year, such as R. John Ellis, F. Ulrich Hartl, Arthur Horwich, Fred H. Gage, and Joan Massague. Check here for detail! If someone among them happened to be your favorite, you even can vote for him on the website. Although your vote doesn't count...
Guess who will be the biggest winner in biomedical sciences this year?
Mainly based on the citations and impacts of the publications, Thomson Scientific has 6 nominees this year, such as R. John Ellis, F. Ulrich Hartl, Arthur Horwich, Fred H. Gage, and Joan Massague. Check here for detail! If someone among them happened to be your favorite, you even can vote for him on the website. Although your vote doesn't count...
Subscribe to Posts [Atom]